Expression of the c-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance

Leukemia and Lymphoma

Volumn 34, Issue 1-2, 1999, Pages 85-94

  Schwartz, S ^a   Heinecke, A ^b   Zimmermann, M ^c   Creutzig, U ^c   Schoch, C ^d,h   Harbott, J ^e   Fonatsch, C ^d,i   Loffler H ^f   Buchner T ^c   Ludwig, W D ^g   Thiel, E ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Inst Med Informatik Biomathematik   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

^g Section of Pathology   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ Inst für Med Biol der Med   (Austria)

Author keywords

Acute myeloid leukemia; C kit receptor; CD117; Cylogenetics; Prognosis

Indexed keywords

CD15 ANTIGEN; CD34 ANTIGEN; RECEPTOR SUBTYPE; STEM CELL FACTOR RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL; CANCER SURVIVAL; CELL STRUCTURE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 0032996540     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909083383     Document Type: Article

References (35)

1. Rosnet, O. and Birnbaum, D. (1993) Hematopoietic receptors of class III receptor-type tyrosine kinases. Critical Reviews in Oncogenesis, 4, 595-613.
2. Broudy, V.C. (1997) Stem cell factor and hematopoiesis. Blood, 90, 1345-1364.
3. Strobl, H., Takimoto, M., Majdic, O., Höcker, P. and Knapp, W. (1992) Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit. British Journal of Haematology, 82, 287-294.
4. Muroi, K., Amemiya, Y. and Miura, Y. (1996) Specificity of CD117 expression in the diagnosis of acute myeloid leukemia. Leukemia, 10, 1048.
5. Kubota, A., Okamura, S., Shimoda, K., Harada, M. and Niho, Y. (1994) The c-kit molecule and the surface immunopheno-type of human acute leukemia. Leukemia and Lymphoma, 14, 421-428.
6. di Noto, R., lo Pardo, C., Schiavone, E.M., Manzo, C., Vacca, C., Ferrara, F. and del Vecchio, L. (1996) Stem cell factor receptor (c-kit, CD117) is expressed on blast cells from most immature types of acute myeloid malignancies but is also a characteristic of a subset of acute promyelocytic leukaemia. British Journal of Haematology, 92, 562-564.
7. Smith, F.O., Broudy, V.C., Zsebo, K.M., Lampkin, B.C., Buckley, C.V., Buckley, J.D., Opie, T., Woods, W.G., Hammond, G.D. and Bernstein, I.D. (1994) Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the childrens cancer group. Blood, 84, 847-852.
8. Muroi, K., Nakamura, M., Amemiya, Y., Suda, T. and Miura, Y. (1995) Expression of c-kit receptor (CD117) and CD34 in leukemic cells. Leukemia and Lymphoma, 16, 297-305.
9. Béné, M.C., Bernier, M., Casasnovas, R.O., Castoldi, G., Knapp, W., Lanza, F., Ludwig, W.D., Matutes, E., Orfao, A., Sperling, C. and van't Veer, M.B. (1998) The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. Blood, 92, 596-599.
10. Reuss-Borst, M.A., Bühring, H.J., Schmidt, H. and Müller, C.A. (1994) AML: Immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia, 8, 258-263.
11. Valverde, L.R., Matutes, E., Farahat, N., Heffernan, A., Owusu-Ankomah, K., Morilla, R. and Catovsky, D. (1996) C-kit receptor (CD117) expression in acute leukemia. Annals of Hematology, 72, 11-15.
12. Wells, S.J., Bray, R.A., Stempora, L.L. and Farhi, D.C. (1996) CD117/CD34 expression in leukemic blasts. Hematopathology, 106, 192-195.
13. Lauria, F., Bagnara, G.P., Rondelli, D., Raspadori, D., Strippoli, P., Bonsi, L., Ventura, M.A., Montanaro, L.L., Bubola, G., Tura, S. and Broudy, V.C. (1995) Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia. Leukemia and Lymphoma, 18, 451-455.
14. Ashman, L.K., Roberts, M.M., Gadd, S.J., Cooper, S.J. and Juttner, C.A. (1988) Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia. Leukemia Research, 12, 923-928.
15. Broudy, V.C., Smith, F.O., Lin, N., Zsebo, K.M., Egrie, J. and Bernstein, I.D. (1992) Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood, 80, 60-67.
16. Ikeda, H., Kanakura, Y., Tamaki, T., Kurui, A., Kitayama, H., Ishikawa, J., Kanayama, Y., Yonezawa, T., Tarui, S. and Griffin, J.D. (1991) Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood, 78, 2962-2968.
17. Pietsch, T., Kyas, U., Steffens, U., Yakisan, E., Hadam, M.R., Ludwig, W.D., Zsebo, K.M. and Welte, K. (1992) Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors. Blood, 80, 1199-1206.
18. Bradstock, K., Matthews, J., Benson, E., Page, F., Bishop, J., and the Australian Leukaemia Study Group (1994) Prognostic value of immunophenotyping in acute myeloid leukemia. Blood, 84, 1220-1225.
19. Mrézek, K., Heinonen, K., de la Chapelle, A. and Bloomfield, C.D. (1997) Clinical significance of cytogenetics in acute myeloid leukemia. Seminars in Oncology, 24, 17-31.
20. Sperling, C., Schwartz, S., Büchner, T., Thiel, E. and Ludwig, W.D. (1997) Expression of the stem cell factor receptor c-kit (CD117) in acute leukemias. Haematologica, 82, 617-621.
21. Creutzig, U., Harbott, J., Sperling, C., Ritter, J., Zimmermann, M., Löfflet, H., Riehm, H., Schellong, G. and Ludwig, W.D. (1995) Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood, 86, 3097-3108.
22. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine, 103, 626-629.
23. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). British Journal of Haematology, 78, 325-329.
24. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1985) Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). Annals of Internal Medicine, 103, 460-462.
25. Stollmann, B., Fonatsch, C. and Havers, W. (1985) Persistent Epstein-Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders. British Journal of Haematology, 60, 183-196.
26. ISCN (1991): Guidelines for cancer cytogenetics. Supplement to an international system for human cytogenetic nomenclature, Mitelman F (ed); S. Karger, Basel, 1991.
27. ISCN (1995): An International System for Human Cytogenetic Nomenclature, Mitelman F (ed); S. Karger, Basel, 1995.
28. Dastugue, N., Payen, C., Lafage-Pochitaloff, M., Bernard, P., Leroux, D., Huguet-Rigal, F., Stoppa, A.M., Marit, G., Molina, L., Michallet, M., Maraninchi, D., Attal, M. and Reiffers, J. (1995) Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia, 9, 1491-1498.
29. Schoch, C., Haase, D., Fonatsch, C., Haferlach, T., Löffler, H., Schlegelberger, B., Hossfeld, D.K., Becher, R., Sauerland, M.C., Heinecke, A., Wörmann, B., Büchner, T. and Hiddemann, W. (1997) The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. British Journal of Haematology, 99, 605-611.
30. Cox, D.R. and Oakes, D. (1984) Analysis of survival data. London: Chapman and Hall.
31. Venditti, A., Del Poeta, G., Buccisano, F., Tamburini, A., Cox, M.C., Stasi, R., Bruno, A., Aronica, G., Maffei, L., Suppo, G., Simone, M.D., Forte, L., Cordero, V., Postorino, M., Tuffili, V., Isacchi, G., Masi, M., Papa, G. and Amadori, S. (1997) Minimally differentiated acute myeloid leukemia (AML-M0): Comparison of 25 cases with other French-American-British subtypes. Blood, 89, 621-629.
32. Porwit-MacDonald, A., Janossy, G., Ivory, K., Swirsky, D., Peters, R., Wheatley, K., Walker, H., Turker, A., Goldstone, A.H. and Burnett, A. (1996) Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). Blood, 87, 1162-1169.
33. Pui, C.H., Kane, J.R. and Crist, W.M. (1995) Biology and treatment of infant leukemias. Leukemia, 9, 762-769.
34. Abrahamson, J.L.A., Lee, J.M. and Bernstein, A. (1995) Regulation of p53-mediated apoptosis and cell cycle arrest by steel factor. Molecular and Cellular Biology, 15, 6953-6960.
35. Löwenberg, B., van Putten, W.L.J., Touw, I.P., Delwel, R. and Santini, V. (1993) Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. The New England Journal of Medicine, 328, 614-619.